Form DRS - Draft Registration Statement:
SEC Accession No. 0001829126-25-002514
Filing Date
2025-04-10
Accepted
2025-04-09 18:23:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 865100
2 filename2.htm EX-23.1 5651
3 GRAPHIC img_001.jpg GRAPHIC 5287
4 GRAPHIC ex23-1_001.jpg GRAPHIC 22772
5 GRAPHIC ex23-1_002.jpg GRAPHIC 6321
  Complete submission text file 0001829126-25-002514.txt   919700
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07875 | Film No.: 25826132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)